ARE * Stock Overview
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
Alexandria Real Estate Equities, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2,350.00 |
| 52 Week High | US$2,350.00 |
| 52 Week Low | US$2,035.10 |
| Beta | 1.18 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 32.02% |
| 33 Year Change | n/a |
| 5 Year Change | -19.80% |
| Change since IPO | 6.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| ARE * | MX Health Care REITs | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | 32.0% | 0% | 0% |
Return vs Industry: ARE * matched the MX Health Care REITs industry which returned 32.2% over the past year.
Return vs Market: ARE * exceeded the MX Market which returned -3.7% over the past year.
Price Volatility
| ARE * volatility | |
|---|---|
| ARE * Average Weekly Movement | n/a |
| Health Care REITs Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: ARE *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine ARE *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 568 | Peter Moglia | www.are.com |
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. Alexandria has a total market capitalization of $34.4 billion and an asset base in North America of 74.1 million SF as of March 31, 2024, which includes 42.2 million RSF of operating properties, 5.3 million RSF of Class A/A+ properties undergoing construction and one committed near-term project expected to commence construction in the next two years, 2.5 million RSF of priority anticipated development and redevelopment projects, and 24.1 million SF of future development projects.
Alexandria Real Estate Equities, Inc. Fundamentals Summary
| ARE * fundamental statistics | |
|---|---|
| Market cap | Mex$370.97b |
| Earnings (TTM) | Mex$5.74b |
| Revenue (TTM) | Mex$62.68b |
64.5x
P/E Ratio5.9x
P/S RatioIs ARE * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARE * income statement (TTM) | |
|---|---|
| Revenue | US$3.09b |
| Cost of Revenue | US$891.56m |
| Gross Profit | US$2.19b |
| Other Expenses | US$1.91b |
| Earnings | US$282.55m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.62 |
| Gross Margin | 71.10% |
| Net Profit Margin | 9.16% |
| Debt/Equity Ratio | 55.9% |
How did ARE * perform over the long term?
See historical performance and comparison